NCT01434043

Brief Summary

This purpose of this research project is to test the diagnostic accuracy (i.e., sensitivity, specificity, positive and negative predictive value, and receiver operator curve area under the curve) of cardiac computed tomography (CT) perfusion as compared to the best non-invasive test of blood flow -- cardiac positron emission transmission (PET) perfusion imaging. The primary outcome of the study is to determine the CT perfusion technique with the highest overall diagnostic accuracy measured by the highest area under the receiver operator curve. The investigators will test 4 different CT perfusion techniques. (A) Qualitative, visual inspection of the contrast-enhanced CT images (B) Enhanced voxel distribution analysis (C) Rate of myocardial contrast enhancement analysis (D) Quantitative heart blood flow using a distributed 2-region analysis A second aim is to reduce the radiation dose needed to maintain CT perfusion diagnostic accuracy. Using the CT perfusion data, the investigators will model the minimal number of cardiac cycle radiation exposures needed to keep the diagnostic accuracy similar to the full data set. A third aim is to test the incremental diagnostic accuracy of CT angiography plus CT perfusion to identify regions of low blood flow as compared to PET perfusion alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 14, 2011

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

6.3 years

First QC Date

September 9, 2011

Last Update Submit

May 8, 2023

Conditions

Keywords

Cardiac CT perfusionPositron emission tomography perfusionQuantitative perfusion

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy measures of cardiac CT perfusion techniques

    Diagnostic performance includes sensitivity, specificity, positive and negative predictive values, and receiver operator curve area under the curve \[ROC AUC\]. The highest ROC AUC will be considered the best diagnostic performance and will be compared statisically using the c-statistic.

    1 month

Secondary Outcomes (2)

  • Minimal number of images needed for CT perfusion

    1 month

  • Diagnostic accuracy of CCTA and CT perfusion compared to PET perfusion imaging alone

    1 month

Study Arms (1)

Myocardial ischemia patients

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults with suspected or known myocardial ischemia

You may qualify if:

  • Patients referred for
  • clinically indicated PET imaging for assessment of myocardial ischemia
  • clinically indicated CCTA scanning with known coronary artery disease
  • ≥20 years of age and ≤ 80 years of age
  • Able to provide written informed consent

You may not qualify if:

  • Contraindications to beta blockers or regadenoson
  • Active reactive airway disease
  • nd or 3rd degree heart block (without a pacemaker)
  • Sick sinus syndrome (without a pacemaker)
  • Long QT syndrome (QTC \> 500 msec)
  • Severe hypotension
  • Decompensated heart failure
  • Pregnancy
  • Contraindications to undergoing any CT imaging procedure with contrast:
  • Irregular heart rhythm despite beta blockade
  • Creatinine \>1.6 mg/dl
  • Allergy to iodinated contrast medium
  • Inability to lie flat

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington Medical Center

Seattle, Washington, 98115, United States

Location

MeSH Terms

Conditions

Myocardial IschemiaCoronary Artery DiseaseMyocardial Infarction

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesCoronary DiseaseArteriosclerosisArterial Occlusive DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Medicine/Cardiology

Study Record Dates

First Submitted

September 9, 2011

First Posted

September 14, 2011

Study Start

September 1, 2011

Primary Completion

December 31, 2017

Study Completion

December 31, 2019

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations